Key facts
- Notable investors include The Family Fund.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Daybreak (Other Devices and Supplies)
- ·The full record, as it builds
Funding rounds
No funding rounds for Daybreak (Other Devices and Supplies) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Daybreak (Other Devices and Supplies)
Developer of an at-home diagnostic and treatment system intended for identifying and addressing obstructive sleep-related breathing conditions. The company's platform provides a finger-worn FDA-cleared sleep test that records physiological indicators for clinical review and a custom-fit mandibular advancement device produced from patient dental impressions, enabling individuals experiencing obstructive sleep apnea to undergo remote evaluation, receive clinician-directed treatment, reduce reliance on in-lab testing, improve nighttime breathing function, and support consistent condition management.
- Sector
- Healthcare
- HQ
- Los Angeles, CA, United States
- Founded
- 2022
- Employees
- 86
- Website
- thedaybreak.com/
- Ownership
- Privately Held (backing)
Daybreak (Other Devices and Supplies) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Daybreak (Other Devices and Supplies) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Daybreak (Other Devices and Supplies) in its N-PORT filings yet. We sweep new filings monthly.